Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Chapter 1Atherogenic Lipoprotein Sub-profilingAllison A Ellington PhD, Iftikhar J Kullo MDChapter 2Effect of Exercise on Oxidative Stress BiomarkersRichard J. BloomerChapter 3Human Total Serum N-GlycomeAndré KleinChapter 4Biomarkers of liver fibrosisThierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert-Bismut, Dominique Thabut, Djamila Messous, Mona Muntenau, Julien Massard, Yves Benhamou and Vlad Ratziu, Chapter 5Nutritional Biochemistry of SpaceflightS. M. Smith and S. R. ZwartChapter 6Biomarkers Related to Aging in Human PopulationsEileen Crimmins, Sarinnapha Vasunilashorn, Jung Ki Kim, Dawn AlleyChapter 7Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Mohamed E Suliman, Elvia García-López, Björn Anderstam, Bengt Lindholm and Peter StenvinkelChapter 8Mechanisms of arterial calcification: spotlight on the inhibitors Gabriele Weissen-Plenz, PhD1, Yvonne Nitschke, MS2, and Frank Rutsch, MD2

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Chapter 1Atherogenic Lipoprotein Sub-profilingAllison A Ellington PhD, Iftikhar J Kullo MDChapter 2Effect of Exercise on Oxidative Stress BiomarkersRichard J. BloomerChapter 3Human Total Serum N-GlycomeAndré KleinChapter 4Biomarkers of liver fibrosisThierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert-Bismut, Dominique Thabut, Djamila Messous, Mona Muntenau, Julien Massard, Yves Benhamou and Vlad Ratziu, Chapter 5Nutritional Biochemistry of SpaceflightS. M. Smith and S. R. ZwartChapter 6Biomarkers Related to Aging in Human PopulationsEileen Crimmins, Sarinnapha Vasunilashorn, Jung Ki Kim, Dawn AlleyChapter 7Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Mohamed E Suliman, Elvia García-López, Björn Anderstam, Bengt Lindholm and Peter StenvinkelChapter 8Mechanisms of arterial calcification: spotlight on the inhibitors Gabriele Weissen-Plenz, PhD1, Yvonne Nitschke, MS2, and Frank Rutsch, MD2

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Chapter 1Atherogenic Lipoprotein Sub-profilingAllison A Ellington PhD, Iftikhar J Kullo MDChapter 2Effect of Exercise on Oxidative Stress BiomarkersRichard J. BloomerChapter 3Human Total Serum N-GlycomeAndré KleinChapter 4Biomarkers of liver fibrosisThierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert-Bismut, Dominique Thabut, Djamila Messous, Mona Muntenau, Julien Massard, Yves Benhamou and Vlad Ratziu, Chapter 5Nutritional Biochemistry of SpaceflightS. M. Smith and S. R. ZwartChapter 6Biomarkers Related to Aging in Human PopulationsEileen Crimmins, Sarinnapha Vasunilashorn, Jung Ki Kim, Dawn AlleyChapter 7Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Mohamed E Suliman, Elvia García-López, Björn Anderstam, Bengt Lindholm and Peter StenvinkelChapter 8Mechanisms of arterial calcification: spotlight on the inhibitors Gabriele Weissen-Plenz, PhD1, Yvonne Nitschke, MS2, and Frank Rutsch, MD2